The Thalamic Energy-Gating Hypothesis of Schizophrenia: A Subtype Model of Thalamocortical Arbitration Failure

Schizophrenia is commonly modeled through dopaminergic, neurodevelopmental, hippocampal, cortical, and glutamatergic frameworks. The present hypothesis proposes that a biologically meaningful subtype of schizophrenia may arise from impaired thalamic energy-gating: failure of thalamocortical relay systems to maintain precise boundaries between external sensory input, internally generated prediction, memory fragments, emotional salience, and irrelevant neural noise. Under this model, the thalamus functions not as a passive relay but as an arbitration hub whose stability depends on thalamic reticular nucleus-mediated inhibition, glutamatergic signaling, astrocytic support, metabolic flexibility, vascular integrity, and cortical feedback. When this gate destabilizes, cortical systems receive degraded, mistimed, excessive, or internally contaminated signal and respond through predictive completion. Hallucinations emerge when these internally completed percepts are misclassified as external reality. Delusions emerge when dopamine-mediated salience systems lock abnormal importance onto corrupted signal, while hippocampal and amygdala systems provide memory content and emotional force. Negative symptoms may reflect compensatory constriction after chronic sensory-cognitive overload. This model predicts that hallucination-heavy schizophrenia will show measurable abnormalities in thalamocortical connectivity, sensory gating, thalamic glutamate/glutamine metabolism, thalamic reticular nucleus-related rhythm markers, metabolic dysfunction, and possibly thalamic blood-brain barrier permeability. It further predicts that adjunctive metabolic or gate-restoring interventions may benefit a biologically defined subgroup when added to standard antipsychotic treatment. The hypothesis is falsifiable through multimodal imaging, magnetic resonance spectroscopy, electroencephalography, metabolic profiling, symptom stratification, and controlled intervention trials.